# NYSTATIN

NDC: 81033-015
Generic name: NYSTATIN
Labeler / Manufacturer: Kesin Pharma Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20200814

FDA application: ANDA062832

## Active ingredients

- NYSTATIN: 100000 U/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81033-015"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81033-015
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43817169-bbe8-58ee-e063-6294a90a1250